Business
Establishment Labs Releases 2021 Sustainability Review
SANTA BARBARA, Calif.--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s
About this update from Establishment Labs Holdings Inc.
[{"type":"text","content":" SANTA BARBARA, Calif.--(BUSINESS WIRE)--\nEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced publication of its 2021 Sustainability Review to coincide with the fourth anniversary of the company’s public listing on NASDAQ.\n\n“Our company was founded to transform the legacy of an industry through a unique commitment to women’s health and wellbeing. On the fourth anniversary of our listing on NASDAQ, we are unveiling our vision to build a new industry where we support women empowered with the freedom to make informed decisions in the journey of breast health and wellness,” said Juan José Chacón-Quirós, Founder and CEO of Establishment Labs. “We are presenting our 2021 Sustainability Review as an exercise in transparency, so that all of our stakeholders can review our progress with this vision and our efforts in support of environmental and social issues in our communities.”\n\nAmong the topics included in the 2021 Sustainability Review are:\n\n\nReferences to the Global Reporting Initiative (GRI) Standards for Energy Consumption, Emissions, and Health and Safety topics as well as the Sustainable Development Goals (SDGs) outlined in the United Nations resolution ‘The 2030 Agenda’.\n\n\n\nAn assessment of the company’s ongoing environmental efforts, including the recertification of its headquarters and manufacturing facilities as carbon neutral according to the Costa Rican national program.\n\n\n\nHighlights from the company’s efforts in promoting women’s health and well-being, including its patient advocacy efforts, its support of breast cancer awareness and breast reconstruction, the launch of Motiva Flora® and JOY® with Ergonomix2, and other programs and initiatives.\n\n\n\nThe publication of landmark breast implant surface research in Nature Biomedical Engineering demonstrating how the Motiva® SmoothSilk® surface significantly reduced foreign-body response compared to implants with high degrees of roughness or completely smooth surfaces that were included in the study.\n\n\n\nA description of the company’s efforts to promote the development of its employees, including ensuring a safe work environment during the COVID-19 pandemic.\n\n\n\nA review of the company’s 2021 financia...